147 related articles for article (PubMed ID: 37683590)
1. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism.
Sun X; Zhang Y; Cheng G; Zhu T; Zhang Z; Xiong L; Hu H; Liu H
Biomed Pharmacother; 2023 Nov; 167():115430. PubMed ID: 37683590
[TBL] [Abstract][Full Text] [Related]
2. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY
Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004
[TBL] [Abstract][Full Text] [Related]
3. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway.
Wang X; Liang F; Dai Z; Feng X; Qiu F
J Ethnopharmacol; 2024 Jan; 318(Pt B):117050. PubMed ID: 37595814
[TBL] [Abstract][Full Text] [Related]
4. Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon.
Cui H; Cai Y; Wang L; Jia B; Li J; Zhao S; Chu X; Lin J; Zhang X; Bian Y; Zhuang P
Front Pharmacol; 2018; 9():571. PubMed ID: 29904348
[TBL] [Abstract][Full Text] [Related]
5. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
[TBL] [Abstract][Full Text] [Related]
6. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
7. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
[TBL] [Abstract][Full Text] [Related]
8. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.
Dong S; Zhu M; Wang K; Zhao X; Hu L; Jing W; Lu H; Wang S
Pharmacol Res; 2021 Sep; 171():105767. PubMed ID: 34273490
[TBL] [Abstract][Full Text] [Related]
9. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
10. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5.
Hua YL; Jia YQ; Zhang XS; Yuan ZW; Ji P; Hu JJ; Wei YM
Biomed Pharmacother; 2021 May; 137():111320. PubMed ID: 33578232
[TBL] [Abstract][Full Text] [Related]
11. Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms.
Yu Z; Li D; Sun H
Biomed Pharmacother; 2023 May; 161():114409. PubMed ID: 36822021
[TBL] [Abstract][Full Text] [Related]
12. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function.
Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L
J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971
[TBL] [Abstract][Full Text] [Related]
13. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades.
Wang K; Guo J; Chang X; Gui S
J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325
[TBL] [Abstract][Full Text] [Related]
14. Berberine inhibits dendritic cells differentiation in DSS-induced colitis by promoting Bacteroides fragilis.
Zheng C; Wang Y; Xu Y; Zhou L; Hassan S; Xu G; Zou X; Zhang M
Int Immunopharmacol; 2021 Dec; 101(Pt A):108329. PubMed ID: 34749293
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of berberine hydrochloride and dehydrocostus lactone in the treatment of ulcerative colitis: Take gut microbiota as the target.
Xu C; Zhao L; Zhou W; Li Y; Hu H; Wang Z
Int Immunopharmacol; 2023 Nov; 124(Pt B):111009. PubMed ID: 37820424
[TBL] [Abstract][Full Text] [Related]
16. Pulsatilla decoction improves DSS-induced colitis via modulation of fecal-bacteria-related short-chain fatty acids and intestinal barrier integrity.
Niu C; Hu XL; Yuan ZW; Xiao Y; Ji P; Wei YM; Hua YL
J Ethnopharmacol; 2023 Jan; 300():115741. PubMed ID: 36162543
[TBL] [Abstract][Full Text] [Related]
17. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
18. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice.
Wang X; Huang S; Zhang M; Su Y; Pan Z; Liang J; Xie X; Wang Q; Chen J; Zhou L; Luo X
J Ethnopharmacol; 2023 Feb; 302(Pt B):115919. PubMed ID: 36356716
[TBL] [Abstract][Full Text] [Related]
19. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
20. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
